Marissa Leal
Family · Portland, TXNPI 1265071260
Payments from drug & device makers
Across 644 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$2K
- AstraZeneca$2K
- Novo Nordisk$1K
- Esperion Therapeutics, Inc.$1K
- Lilly USA, LLC$1K
- Mannkind Corporation$896
- plus $7K from 33 others
What the payments were for
- Food & beverage$15,322100%
- Education$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 70 | $2,318 |
| AstraZeneca(2 entities) | 60 | $1,797 |
| Novo Nordisk | 80 | $1,306 |
| Esperion Therapeutics, Inc. | 28 | $1,270 |
| Lilly USA, LLC | 58 | $1,017 |
| Mannkind Corporation | 23 | $896 |
| Medtronic | 48 | $851 |
| Xeris Pharmaceuticals, Inc. | 29 | $573 |
| Boehringer Ingelheim | 23 | $453 |
| Amgen(2 entities) | 19 | $442 |
| Insulet Corporation | 10 | $427 |
| Sanofi-aventis U.S. LLC | 21 | $421 |
| Amarin Pharma, Inc. | 21 | $384 |
| Tandem Diabetes Care, Inc. | 6 | $355 |
| AbbVie | 19 | $320 |
| Zealand Pharma US, Inc. | 18 | $293 |
| Corcept Therapeutics | 12 | $271 |
| Ultragenyx Pharmaceutical Inc. | 13 | $219 |
| Clarus Therapeutics Inc. | 7 | $198 |
| Recordati_rare_diseases_inc. | 4 | $182 |
| Radius Health, Inc. | 8 | $168 |
| Antares Pharma, Inc. | 20 | $165 |
| Viiv Healthcare Company | 2 | $155 |
| Ascendis Pharma Endocrinology Inc | 3 | $138 |
| Nestle Healthcare Nutrition Inc. | 8 | $117 |
| Intuity Medical Inc | 2 | $90 |
| BD | 4 | $73 |
| Merck | 4 | $72 |
| Novartis | 4 | $61 |
| Vivus LLC | 4 | $59 |
| Acerus Pharmaceuticals Corporation | 3 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| GRT US Holding, Inc. | 3 | $39 |
| Lifescan, Inc. | 3 | $39 |
| Cequr Corporation | 1 | $36 |
| Gilead | 1 | $23 |
| Bigfoot Biomedical Inc | 1 | $22 |
| EMD Serono, Inc. | 1 | $17 |
| EUSA Pharma (US) LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,368 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Portland
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.